PFKM and colorectal carcinoma: Mechanically, we found that TZP exerted its anti‐CRC effect by inhibiting glucose influx and targeting HIF‐1α for degradation with reduced expression of its downstream glycolytic gene PFKFB3 and PFK‐1, leading to reduced glycolysis and TCA in the cancer tissues.